STEVEN A. KRIEGSMAN - Corporate Board Profile

LadRx Corp

Filing Date	Source Excerpt
2003-09-17	Steven A. Kriegsman (61) has been a director and our Chief Executive Officer since July 2002. ... Under his employment agreement, during the performance period Mr. Kriegsman was paid a salary of $110,000.
2004-06-30	Steven A. Kriegsman (62) has been a director and CEO since July 2002 and President since January 12, 2004. His 2003 compensation included salary of $313,772 and a bonus of $1,000,000.
2005-06-07	Steven A. Kriegsman (63) has been a director and our President and Chief Executive Officer since July 2002. ... During 2004, our non-employee directors received a quarterly retainer of $1,500 and a fee of $1,500 for each board meeting attended ... directors who were employees of our company received no compensation for their service as directors or as members of Board committees.
2006-06-12	Steven A. Kriegsman (64) has been a director and our President and Chief Executive Officer since July 2002. ... Mr. Kriegsman’s total compensation for 2005 includes a bonus of $399,403, salary of $0, and other compensation of $11,500, plus stock options granted.
2007-05-24	Steven A. Kriegsman (65) has been a director and our President and Chief Executive Officer since July 2002. He also serves as a director of our majority-owned subsidiary, RXi Pharmaceuticals Corporation. He previously served as Director and Chairman of Global Genomics from June 2000. Mr. Kriegsman is an inactive Chairman and Founder of Kriegsman Capital Group LLC, a financial advisory firm specializing in the development of alternative sources of equity capital for emerging growth companies in the healthcare industry. He has advised such companies as SuperGen Inc., Closure Medical Corporation, Novoste Corporation, Miravant Medical Technologies, and Maxim Pharmaceuticals. Mr. Kriegsman has a BS degree with honors from New York University in Accounting and completed the Executive Program in Mergers and Acquisitions at New York University, The Management Institute. Mr. Kriegsman was formerly a Certified Public Accountant with KPMG in New York City. He serves as a Director and is the former Chairman of the Audit Committee of Bradley Pharmaceuticals, Inc. In February 2006, Mr. Kriegsman received the Corporate Philanthropist of the Year Award from the Greater Los Angeles Chapter of the ALS Association and in October 2006, he received the Lou Gehrig Memorial Corporate Award from the Muscular Dystrophy Association. Mr. Kriegsman has been active in various charitable organizations, including the Biotechnology Industry Organization, the ALS Association, the Los Angeles Venture Association, the Southern California Biomedical Council, and the Palisades-Malibu YMCA.
2008-05-23	Steven A. Kriegsman (66) has been a director and our President and Chief Executive Officer since July 2002. He also serves as a director of RXi. He previously served as Director and Chairman of Global Genomics from June 2000 until our merger with Global Genomics in July 2002. Mr. Kriegsman is the Chairman of the Board and founder of Kriegsman Capital Group LLC, a financial advisory firm specializing in the development of alternative sources of equity capital for emerging growth companies in the healthcare industry. ... Mr. Kriegsman does not receive additional compensation for his role as a Director. For information relating to Mr. Kriegsman’s compensation as President and Chief Executive Officer, see the Summary Compensation Table above. Summary Compensation Table shows total compensation of $1,120,301 in 2007.
2009-05-11	Steven A. Kriegsman (67) has been a director and our President and Chief Executive Officer since July 2002. ... Steven A. Kriegsman does not receive additional compensation for his role as a Director. For information relating to Mr. Kriegsman’s compensation as President and Chief Executive Officer, see the Summary Compensation Table above.
2010-05-18	Steven A. Kriegsman (68) has been CytRx’s President and Chief Executive Officer and a director since July 2002. ... Steven A. Kriegsman does not receive additional compensation for his role as a Director. For information relating to Mr. Kriegsman’s compensation as President and Chief Executive Officer, see the Summary Compensation Table above.
2011-05-17	Steven A. Kriegsman (69) has been has been CytRx’s President and Chief Executive Officer and a director since July 2002.
2012-04-02	Steven A. Kriegsman (70) has been CytRx’s President and Chief Executive Officer and a director since July 2002. ... Summary Compensation Table: Steven A. Kriegsman, President and Chief Executive Officer, 2011 Total Compensation $1,202,000. ... Steven A. Kriegsman does not receive additional compensation for his role as a Director.
2013-05-17	Steven A. Kriegsman (71) has been CytRx’s President and Chief Executive Officer and a director since July 2002. ... Steven A. Kriegsman does not receive additional compensation for his role as a director. ... Summary Compensation Table ... Steven A. Kriegsman ... 2012 ... $700,000 Salary ... $150,000 Bonus ... $655,000 Option Awards ... $13,700 All Other Compensation ... $1,518,700 Total.
2014-05-01	Steven A. Kriegsman (72) has been CytRx’s President and Chief Executive Officer and a director since July 2002. He also serves as a director of Galena Biopharma, a listed public company, and is Chairman of its Compensation Committee and a member of its Strategy Committee. Mr. Kriegsman also serves on the Board of Directors of Catasys, Inc. He previously served as Director and Chairman of Global Genomics from June 2000 until 2002. Mr. Kriegsman is an inactive Chairman and Founder of Kriegsman Capital Group LLC, a financial advisory firm specializing in the development of alternative sources of equity capital for emerging growth companies in the healthcare industry. During his career, he has advised such companies as SuperGen Inc., Closure Medical Corporation, Novoste Corporation, Miravant Medical Technologies, and Maxim Pharmaceuticals. In the past five years, Mr. Kriegsman has also served on the Board of Directors of Bradley Pharmaceuticals, Inc. and Hythiam, Inc. Mr. Kriegsman has a B.S. degree with honors from New York University in Accounting and completed the Executive Program in Mergers and Acquisitions at New York University, The Management Institute. Mr. Kriegsman is a graduate of the Stanford Law School Directors’ College. Mr. Kriegsman was formerly a Certified Public Accountant with KPMG in New York City. In February 2006, Mr. Kriegsman received the Corporate Philanthropist of the Year Award from the Greater Los Angeles Chapter of the ALS Association and in October 2006, he received the Lou Gehrig Memorial Corporate Award from the Muscular Dystrophy Association. Mr. Kriegsman has been a guest speaker and lecturer at various universities including California Institute of Technology (Caltech), Brown University, and New York University. Mr. Kriegsman has been active in various charitable organizations including the Biotechnology Industry Organization, the California Health Institute, the ALS Association, the Los Angeles Venture Association, the Southern California Biomedical Council, the American Association of Dance Companies and the Palisades-Malibu YMCA. Mr. Kriegsman does not receive additional compensation for his role as a Director. For information relating to Mr. Kriegsman’s compensation as President and Chief Executive Officer, see the Summary Compensation Table above.
2015-05-05	Steven A. Kriegsman is Chairman and CEO. Summary Compensation Table shows total compensation of $2,191,700 for 2014. He does not receive additional compensation for his role as Chairman or director.
2016-05-20	Steven A. Kriegsman (74) has been CytRx's Chairman and Chief Executive Officer since October 2014. ... The following table presents summary information concerning all compensation paid or accrued by us for services rendered in all capacities during 2015: ... Steven A. Kriegsman Chief Executive Officer 2015 Salary 850,000 Bonus 150,000 Option Awards 1,593,000 All Other Compensation 13,700 Total 2,606,700 ... Steven A. Kriegsman does not receive additional compensation for his role as Chairman of the Board.
2017-05-22	Steven A. Kriegsman (75) has been CytRx's Chairman of the Board and Chief Executive Officer since October, 2014 and a director since July 2002. ... Mr. Kriegsman's extensive history as a member of management is vital to the board of directors' collective knowledge of our day-to-day operations. ... Summary Compensation Table shows total compensation of $2,402,450 for 2016.
2017-08-29	Name of Beneficial Owner Named Executive Officers and Directors Steven A. Kriegsman 6,411,154 Includes 3,488,462 shares subject to options or warrants.
2018-07-05	Steven A. Kriegsman (76) has been CytRx Corporation’s President and Chief Executive Officer and a director since July 2002, and Chairman of the Board since 2014. Mr. Kriegsman’s extensive history as a member of management is vital to the board of directors’ collective knowledge of our day-to-day operations. He also provides great insight as to how CytRx grew as an organization and his institutional knowledge is an invaluable asset to the board of directors in effecting its oversight of CytRx’s strategic plans. Mr. Kriegsman’s presence on the board of directors allows for a flow of information and ideas between the board of directors and management. Our non-employee directors receive a combination of cash and stock-based compensation. Directors who also are employees of our Company currently receive no additional compensation for their service as directors or as members of board committees.
2019-06-26	Steven A. Kriegsman (77) has been CytRx’s Chief Executive Officer and a director since July 2002. In October 2014, he was elected Chairman of the Board. The following table presents summary information concerning all compensation paid or accrued by us for services rendered in all capacities during 2018 by Steven A. Kriegsman: Salary $850,000, Bonus $150,000, All Other Compensation $13,700, Total $1,013,700. Steven A. Kriegsman does not receive additional compensation for his role as Chairman of the Board.
2020-06-12	Steven A. Kriegsman (78) has been CytRx’s Chief Executive Officer and a director since July 2002. In October 2014, he was elected Chairman of the Board.
2021-06-14	Steven A. Kriegsman, Chairman and Chief Executive Officer. Summary Compensation Table: Steven A. Kriegsman, Chief Executive Officer, 2020 total compensation $1,013,700. He does not receive additional compensation for his role as Chairman of the Board.
2022-01-31	Name of Beneficial Owner Steven A. Kriegsman